School of Medicine
Showing 10,001-10,050 of 13,049 Results
-
Anuja Anand Sathe
Instructor, Medicine - Oncology
Current Research and Scholarly InterestsI am interested in understanding the determinants of therapeutic resistance in cancer. I investigate the composition of the tumor microenvironment and adaptive responses to therapy using single-cell and spatial approaches.
-
Ansuman Satpathy, MD, PhD
Associate Professor of Pathology
Current Research and Scholarly InterestsOur lab works at the interface of immunology, cancer biology, and genomics to study cellular and molecular mechanisms of the immune response to cancer. In particular, we are leveraging high-throughput genomic technologies to understand the dynamics of the tumor-specific T cell response to cancer antigens and immunotherapies (checkpoint blockade, CAR-T cells, and others). We are also interested in understanding the impact of immuno-editing on the heterogeneity and clonal evolution of cancer.
-
Neda Sattarnezhad Oskouei, MD, MS
Instructor, Medicine - Immunology & Rheumatology
BioDr. Neda Sattarnezhad Oskouei is a board-certified neurologist and neuroimmunologist specializing in Multiple Sclerosis (MS) and neuroimmunological disorders, including Neuromyelitis Optica (NMO), MOG Antibody Disease (MOGAD), optic neuritis, transverse myelitis, autoimmune encephalitis, neuro-rheumatological conditions, and neuroinfectious diseases. Her research focuses on understanding the role of pathogens in triggering autoimmunity, with a particular emphasis on the role of Epstein-Barr Virus (EBV) in the development of MS.
Dr. Sattarnezhad earned her MD degree with honors from Tabriz University of Medical Sciences. She completed a research fellowship in Multiple Sclerosis at the Brigham MS Center, Harvard Medical School, before pursuing her residency in adult neurology at the University of Illinois at Chicago. She further specialized by completing a clinical fellowship in Multiple Sclerosis and Neuroimmunology at Stanford University as a Sylvia Lawry Fellow of the National MS Society, during which she also earned a master’s degree in Epidemiology and Clinical Research. She subsequently completed a fellowship in immunology and rheumatology at Stanford.
Her research and training have been supported by the National MS Society (NMSS), National Institutes of Health (NIH), and National Institute of Allergy and Infectious Diseases (NIAID). -
Amelia Sattler, MD
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsCurrently working on projects identifying effective use of actual patient encounters in undergraduate medical education. Specifically interested in the role of actual patient encounters in the training of shared decision making. Also interested in medical student empathy and physician wellness.
Also working on many different projects in the realm of quality improvement and population health in the Division of Primary Care and Population Health. -
Maureen Satyshur
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Satyshur is a licensed clinical psychologist who specializes in Acceptance and Commitment Therapy, Dialectical Behavioral Therapy, as well as interventions for LGBTQ+ individuals.
-
Andrew Saunders
Clinical Associate Professor, Pediatrics
BioDr. Saunders (he/him) is a Clinical Associate Professor of Pediatrics, and the medical director of the Pediatric Hospitalist Program at SHC Tri-Valley. His academic interests include diversity, equity, and inclusion in medicine; LGBTQIA+ health; ethics in technology; global health; medical education; public health; and physician wellness.
-
Vidushi Savant
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Savant specializes in the treatment of comorbid psychiatric disorders in medically ill patients.
She is a double board certified in Psychosomatic Medicine and General Psychiatry. -
Amitoj Singh
Ph.D. Student in Stem Cell Biology and Regenerative Medicine, admitted Autumn 2024
BioAmitoj is a PhD student studying Stem Cell Biology at the Stanford University School of Medicine. He is interested in pursuing research projects in the field of cardiovascular medicine and regenerative therapeutics.
-
Anjali Bhatt Saxena, MD FASN
Clinical Professor (Affiliated), Medicine - Med/Nephrology
BioDr. Anjali Bhatt Saxena, MD is a Clinical Professor of Medicine (Affiliated) at Stanford University School of Medicine and the Director of Peritoneal Dialysis at the Santa Clara Valley Medical Center in San Jose, California. She has served as the Medical Director for an independent Peritoneal Dialysis (PD) Clinic in San Jose, CA since 2004, overseeing a large Peritoneal Dialysis clinic.
Dr. Saxena's clinical and research interests are in the area of home dialysis, including Peritoneal Dialysis and Home Hemodialysis. She is devoted to sharing her home dialysis expertise through research and education worldwide. She has been a key faculty member of Home Dialysis University (HDU) since 2007, providing home dialysis education to hundreds of US Nephrology Fellows and Nephrologists at all levels of experience; in 2024 she became HDU Program Director. She serves on the ASN Home Dialysis Steering Committee and is a founding member of the International Home Dialysis Consortium (ISN-ISPD). She has delivered numerous invited lectures at international meetings and has published scholarly work on PD in various peer-reviewed journals. Dr. Saxena is dedicated to the growth of PD worldwide; she is the immediate past-Treasurer for the International Society for Peritoneal Dialysis (ISPD) and Past-President of the N. American Chapter of ISPD. She is an Educational Ambassador for the ISN, and with colleagues supported the growth of PD in low income areas of Sri Lanka. -
Parnika Prashasti Saxena
Clinical Professor, Psychiatry and Behavioral Sciences
BioParnika Saxena is board certified in general and geriatric psychiatry. She completed her residency at St Elizabeth's Medical Center (affiliated with Tufts University School of Medicine) in Massachusetts and a clinical geriatric fellowship at the University of California, Los Angeles. She also worked as a research fellow in Clinical Psychopharmacology at Mclean Hospital (affiliated with Harvard Medical School) and also completed a psychoanalytic psychotherapy fellowship from the Boston Psychoanalytic Society and Institute. Her primary research interests lie in pharmacological and interventional treatments for resistant depression. At Stanford, she works on the inpatient service, outpatient geropsychiatry clinic and the electroconvulsive therapy service. She also serves at the program director of the Geriatric Psychiatry Fellowship. In addition to her clinical and research interests, she is passionate about patient advocacy and promoting mental health legislative changes to benefit patient care and has testified in state senate hearings to that end as a physician representative of organizations like the Northern California Psychiatric Association and American Psychiatric Association.
-
Nazish Sayed MD, PhD
Associate Professor (Research) of Surgery (Vascular Surgery)
Current Research and Scholarly InterestsThe Sayed Laboratory is focused on the development of novel technologies that drive innovation in regenerative medicine, disease modeling, and drug testing in vascular biology. The lab conducts translational research in vascular biology and aims to understand the role of the vasculature in the development of cardiac diseases, including those due to inherited genetic variants or environmental insults such as type 2 diabetes or hypertension. The lab employs the human induced pluripotent stem cell (iPSC) technology to generate patient-specific vascular cells (endothelial and vascular smooth muscle cells) as an alternative to animal models providing a human tissue surrogate for research that is scalable and sustainable. By employing this unique platform, the lab also investigates the role of chemotherapeutic agents (anti-cancer drugs) on the vasculature. Dr. Sayed’s lab has also established an endothelial regeneration program, where they leverage the innate immune system to regenerate endothelial cells from human fibroblasts.
Work from the lab has led to seminal discoveries in the areas of 1) Nitric oxide (NO) biology, (2) vascular biology, (3) stem cell biology, (4) cardiovascular disease modeling (5) cardio-oncology. -
Michael Scahill
Clinical Assistant Professor, Pediatrics - Neonatology
BioOn a trip to Mozambique while in med school here at Stanford, Dr Scahill saw the power of market interventions to transform healthcare. This led to his current focus on technology, data & AI. A veteran data scientist, his research trawls the oceans of data each patient generates for patterns to predict dangerous outcomes before they happen in Stanford's top level NICU, where he also still serves as a frontline clinician. Outside Stanford, he is the digital lead at Valley Children's hospital and advises health technology startups in Silicon Valley and beyond.
-
John Scandling
Professor of Medicine (Nephrology) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsTolerance induction in clinical kidney transplantation
-
Blake K. Scanlon, Ph.D.
Adjunct Lecturer, Psych/Public Mental Health & Population Sciences
BioThe overarching aim of Dr. Scanlon’s research is to develop and evaluate low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. To that end, the Caregiver Technology Division of the Scanlon Lab aims to enhance patient- and family-centered care through novel, broadly customizable, and highly scalable caregiver interventions. In parallel, the Neurodegenerative Division of the Scanlon Lab focuses on the development and application of cognitive, neuropsychiatric, and biological markers for the initiation and progression of neurodegeneration.
Dr. Scanlon received his bachelor’s degree in Neuroscience and doctorate in Clinical Health Psychology from the University of Miami. After concluding his clinical internship in Geropsychology/Neuropsychology at the VA Palo Alto Health Care System (VAPAHCS), he completed fellowships in Aging and Dementia at Stanford University School of Medicine and VAPAHCS. Dr. Scanlon is currently a VA Career Development Awardee in the Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC) and Stanford/VA Aging Clinical Research Center where his work focuses on developing and evaluating low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. He also serves as Co-Director of the Stanford/VA California Alzheimer's Disease Center, Chair of the VAPAHCS Dementia Committee, and Co-Chair of the Department of Veterans Affairs VISN 21 Dementia Committee. -
Lidia Schapira
Professor of Medicine (Oncology)
BioDr. Schapira is a medical oncologist with clinical expertise in the treatment of breast cancer. As the inaugural Director of Stanford's Cancer Survivorship Program, she has developed a thriving research and clinical program focused on optimizing health outcomes for people living with and beyond cancer. Dr. Schapira is interested in training future generations of physician-scientists as well as the broader community of practicing physicians through the design of innovative educational programs. Dr. Schapira's advocacy for people with cancer led to her appointment as Editor-in-Chief of the American Society of Clinical Oncology's website for the public,Cancer.Net, a position she held from 2015 until-2021. She served on the Board of Directors of the American Psychosocial Oncology Society and as Chair of the Psychosocial Interest Group of the Multinational Society for Supportive Care in Cancer. Dr. Schapira is particularily committed to reducing inequities in cancer outcomes and improve access to cancer care and cancer clinical trials. Dr. Schapira has published numerous manuscripts, lectures both nationally and internationally on issues of cancer survivorship and served as Associate Editor of the narrative section, Art of Oncology, for the Journal of Clinical Oncology from 2013 until 2023.
-
Salena Schapp
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Salena Schapp is a licensed psychologist (PSY29619) and Co-Founder of Beyond Measure. She has experience treating patients across the lifespan, and a particular specialty working with children, adolescents, and families. In her work with children and families, Dr. Schapp is collaborative, compassionate, and playful. She provides a range of psychological services, specializing in treatment of eating disorders, anxiety, behavioral challenges, and trauma. Dr. Schapp is passionate about helping families create a supportive and strong parent-child relationship. She uses evidenced-based approaches to therapy, while individualizing treatment to match each patient’s needs, including cognitive behavioral therapy, family-based therapy, parent management training, parent-child interaction therapy, acceptance and commitment therapy, and dialectical behavioral therapy. She practices from a weight-inclusive, Health at Every Size (HAES)® approach, to help individuals improve their relationship to food and their bodies. Dr. Schapp also has extensive experience with group therapy, and enjoys creating a supportive, safe, and helpful group environment. She is an Adjunct Clinical Assistant Professor for the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine, where she runs a support group for psychiatry residents.
Dr. Schapp completed her graduate training in clinical psychology at the PGSP-Stanford PsyD Consortium, where she focused her studies on children and families. She finished her predoctoral internship training at University of Texas Austin/Dell Children’s Medical Center and her postdoctoral residency at Kaiser Permanente in Redwood City. Dr. Schapp enjoys giving back to the psychological community, and currently serves as the President of the SF Bay Area Chapter of the International Association for Eating Disorder Professionals. She has a strong interest in teaching and supervision, and has provided training opportunities and supervision for trainees at Kaiser Permanente and Beyond Measure. She also enjoys consulting with and teaching other professionals and the community at large through trainings and presentations. -
Alan F. Schatzberg
Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsBiological bases of depressive disorders;, glucocorticoid/dopamine interactions in delusional depression;, pharmacologic treatment of depressive disorders.
